期刊文献+

Wnt2、Wnt3a和β-catenin在硬皮病患者皮损中的作用 被引量:7

Role of Wnt 2,Wnt 3a and β-catenin in skin lesions of patients with scleroderma
下载PDF
导出
摘要 目的探讨Wnt/β-catenin信号通路异常活化在硬皮病(SD)发病机制中的作用及其与SD临床分型的关系。方法采用免疫组织化学SP法检测45例SD患者[系统性硬化症(SSc)25例,局限性硬皮病(LSc)20例]皮损中Wnt2、Wnt3a及β-catenin的量与分布,以20例健康成人皮肤作为正常对照(NC)。结果 Wnt2、Wnt3a分别定位于SD患者皮损真、表皮胞浆和胞核,β-catenin定位于真皮类成纤维细胞、外分泌腺上皮细胞及浸润淋巴细胞的胞核及NC、部分SD表皮细胞的胞膜;SD皮损中Wnt2胞浆着色、Wnt3a及β-catenin核着色均显著高于NC(P<0.01),而β-catenin膜着色则明显低于NC(P<0.01);Wnt2、Wnt3a分别与β-catenin核着色呈正相关(r=0.663,0.654,P<0.01),而与β-catenin膜着色呈负相关(r=-0.532,-0.529,P<0.01);SSc上述3种蛋白的着色与LSc间的差异无统计学意义(P>0.05)。结论 SD皮损中存在的异常活化的Wnt/β-catenin信号在其发病机制中可能起重要作用;LSc和SSc分居于SD病谱的两端而非两种独立疾病。 Objective To study the role of abnormally activated Wnt β-catenin signal pathway in the pathogenesis of scleroderma (SD) and its association with the clinical classification of SD. Methods The expression and distribution of Wnt 2, Wnt 3a, and ^-catenin in the skin lesions of 45 SD patients, including 25 with systemic sclerosis (SSc) and 20 with localized scleroderma (LSc), were detected with SP immunohistochemistry, using 20 samples from healthy skin tissues as normal control. Results In the dermis and epidermis of the SD skin lesions, Wnt 2 and Wnt 3a were located in the cytoplasm and cell nuclei, respectively; ^-catenin was distributed in the nuclei of dermal fibroblast-like ceils, glandular epithelium cells and infiltrating lymphocytes, and on the cell membrane in normal and a part of the affected epidermis. The skin lesions of SD patients showed obviously increased staining intensity of cytoplasmic Wnt 2, nuclear Wnt 3a and β-catenin, but markedly lowered cell membrane staining of β-catenin than normal skins (P〈0.01). Both Wnt 2 and Wnt 3a were positively correlated with nuclear β-catenin deposition (r=0.663 and 0.654, P〈0.01) and negatively with cell membrane β-catenin staining (r=-0.532 and -0.529, P〈0.01). No significant difference was found in the staining intensities of the 3 proteins between SSc and LSc (P〉 0.05). Conclusion Abnormal activation of Wnt/β-catenin pathway occurs in the skin lesions of SD patients, which may play an important role in the pathogenesis of SD. SSc and LSc represent the two opposite ends of the SD spectrum rather than two separate diseases.
作者 刘金娟 刘彤
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第12期1781-1786,共6页 Journal of Southern Medical University
基金 陕西省科技攻关项目(2008K15-06)
关键词 硬皮病 WNT Β-CATENIN 发病机制 免疫组织化学 scleroderma Wnt β-catenin pathogenesis immunohistochemistry
  • 相关文献

参考文献24

  • 1Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder[J]. J Clin Invest, 2007, 117(3): 557-67.
  • 2Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers[J]. Curr Opin Rheumatol, 2012, 24(2): 165-70.
  • 3Gupta RA, Fiorentino D. Localized scleroderma and systemic sclerosis: is there a connection[J]? Best Pract Res Clin Rheumatol, 2007, 21(6): 1025-36.
  • 4Myung S J, Yoon JH, Gwak GY, et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells [J]. FEBS Lett, 2007, 581(16): 2954-8.
  • 5He W, Dai C, Li Y, et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis[J]. J Am Soc Nephrol, 2009, 20(4): 765-76.
  • 6Colston JT, de la Rosa SD, Koehler M, et al. Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor[J]. Am J Physiol Heart Circ Physiol, 2007, 293(3): H1839-46.
  • 7Henderson WJ, Chi EY, Ye X, et al. Inhibition of Wnt/beta-catenin/ CREB binding protein (CBP) signaling reverses pulmonary fibrosis [J]. Proc Natl Acad Sci USA, 2010, 107(32): 14309-14.
  • 8Bayle J, Fitch J, Jacobsen K, et al. Increased expression of Wnt2and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis[J]. J Invest Dermatol, 2008, 128(4): 871-81.
  • 9Beyer C, Schramm A, Akhmetshina A, et al. 13-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis[J]. Ann Rheum Dis, 2012, 71(5): 761-7.
  • 10Wei J, Fang F, Lain AP, et al. Wnt-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells[J]. Arthritis Rheum, 2012, 64(8): 2734-45.

二级参考文献40

  • 1Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder[J]. J Clin Invest, 2007, 117(3): 557-67.
  • 2Franz M, Spiegel K, Umbreit C, et al. Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma[J]. Histochem Cell Biol, 2009, 131(5): 651-60.
  • 3Ishida W, Mori Y, Lakos G, et al. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo[J]. J Invest Dermatol, 2006, 126(8): 1733-44.
  • 4Ihn H, Yamane K, Tamaki K. Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts[J]. J Invest Dermatol, 2005, 125(2): 247-55.
  • 5Sato M, Hirayama S, Lara-Guerra H, et al. MMP-dependent migration of extrapulmonary myofibroblast progenitors contributing to posttransplant airway fibrosis in the lung[J]. Am J Transplant, 2009, 9(5): 1027-36.
  • 6Wu Z, Yang LL, Cai L, et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse[J]. Respir Res, 2007, 8(1): 1-11.
  • 7Qi Q, Guo Q, Tan G, et al. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients [J]. J Eur Acad Dermatol Venereol, 2009, 23(2): 160-8.
  • 8Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortalityin systemic sclerosis: an international meta-analysis of individual patient data[J]. Am J Med, 2005, 118(1): 2-10.
  • 9Schulz SW, Derk CT. Systemic sclerosis at the cellular level: molecular pathways of pathogenesis and its implication on future drug design[J]. Curr Med Chem, 2009, 16(30): 3986-95.
  • 10Lee HM, Kang H J, Park HH, et al. Effect of peroxisome proliferator-activated receptor gamma agonists on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts[J]. Ann Otol Rhinol Laryngol, 2009, 118(10): 721-7.

共引文献8

同被引文献73

  • 1黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1283
  • 2张艺,杨恬,曾益军.β-catenin在大鼠毛囊损伤修复中表达变化的研究[J].创伤外科杂志,2004,6(6):448-450. 被引量:5
  • 3MUELLER KA, MUELLER II, EPPLER D, et al. Clinical and histopathological features of patients with systemic sclerosis un- dergoing endomyocardial biopsy [ J ]. PLoS One, 2015,10 ( 5 ) : e0126707.
  • 4TYNDALL AJ, BANNERT B, VONK M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database[ J]. Ann Rheum Dis,2010, 69(10) :1809 - 1815.
  • 5CLARA DEES CB ,DISTLER JW. Morphogen pathways as molec- ular targets for the treatment of fibrosis in systemic sclerosis[ J ]. Arch Dermatol Res, 2013, 305 ( 1 ) : 1 - 8.
  • 6YU J, VIRSHUP DM. Updating the Wnt pathways [ J]. BiosciRep,2014,34(5 ) : e00142.
  • 7VAN HAL TW, VAN BON L, RADSTAKE TR. A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosis [ J ]. lnt J Rheumatol, 2011, 2011:824972.
  • 8MA J, WANG RQ, FANG XF,et al. -catenin/TCF-1 pathway in T cell development and differentiation [ J ]. J Neuroimmune Pharmacol, 2012, 7(4): 750-762.
  • 9WU B, CRAMPTON SP, HUGHES CC. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmi- gration [ J ]. Immunity, 2007, 26 ( 2 ) : 227 - 239.
  • 10WEI J, FANG F, LAM AP,et al. Wnt/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells [ J ]. Arthritis Rheum, 2012, 64 ( 8 ) :2734 - 2745.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部